Editorial comment on: Cizolirtine citrate, an effective treatment for symptomatic patients with urinary incontinence secondary to overactive bladder: a pilot dose-finding study.
May
Florian
F
Bauer
Ricarda
R
D015740:Calcitonin Gene-Related Peptide / Q000378:metabolism; D005260:Female; D006801:Humans; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D011720:Pyrazoles / Q000008:administration & dosage*; D013373:Substance P / Q000378:metabolism; D053201:Urinary Bladder, Overactive / Q000150:complications / Q000188:drug therapy*; D014549:Urinary Incontinence / Q000188:drug therapy* / Q000209:etiology
D018727:Muscarinic Antagonists; D011720:Pyrazoles; D013373:Substance P; D015740:Calcitonin Gene-Related Peptide; C075798:cizolirtine